These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35189702)

  • 21. Vfr Directly Activates exsA Transcription To Regulate Expression of the Pseudomonas aeruginosa Type III Secretion System.
    Marsden AE; Intile PJ; Schulmeyer KH; Simmons-Patterson ER; Urbanowski ML; Wolfgang MC; Yahr TL
    J Bacteriol; 2016 May; 198(9):1442-50. PubMed ID: 26929300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modified needle-tip PcrV proteins reveal distinct phenotypes relevant to the control of type III secretion and intoxication by Pseudomonas aeruginosa.
    Sato H; Hunt ML; Weiner JJ; Hansen AT; Frank DW
    PLoS One; 2011 Mar; 6(3):e18356. PubMed ID: 21479247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glutathione Activates Type III Secretion System Through Vfr in
    Zhang Y; Zhang C; Du X; Zhou Y; Kong W; Lau GW; Chen G; Kohli GS; Yang L; Wang T; Liang H
    Front Cell Infect Microbiol; 2019; 9():164. PubMed ID: 31157178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hfq and sRNA 179 Inhibit Expression of the Pseudomonas aeruginosa cAMP-Vfr and Type III Secretion Regulons.
    Janssen KH; Corley JM; Djapgne L; Cribbs JT; Voelker D; Slusher Z; Nordell R; Regulski EE; Kazmierczak BI; McMackin EW; Yahr TL
    mBio; 2020 Jun; 11(3):. PubMed ID: 32546612
    [No Abstract]   [Full Text] [Related]  

  • 25. Yersinia Type III Secretion System Master Regulator LcrF.
    Schwiesow L; Lam H; Dersch P; Auerbuch V
    J Bacteriol; 2015 Dec; 198(4):604-14. PubMed ID: 26644429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Salicylidene Acylhydrazides and Hydroxyquinolines Act as Inhibitors of Type Three Secretion Systems in Pseudomonas aeruginosa by Distinct Mechanisms.
    Anantharajah A; Buyck JM; Sundin C; Tulkens PM; Mingeot-Leclercq MP; Van Bambeke F
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28396545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Primed Subpopulation of Bacteria Enables Rapid Expression of the Type 3 Secretion System in Pseudomonas aeruginosa.
    Lin CK; Lee DSW; McKeithen-Mead S; Emonet T; Kazmierczak B
    mBio; 2021 Jun; 12(3):e0083121. PubMed ID: 34154400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spermidine Is an Intercellular Signal Modulating T3SS Expression in Pseudomonas aeruginosa.
    Lin Q; Wang H; Huang J; Liu Z; Chen Q; Yu G; Xu Z; Cheng P; Liang Z; Zhang LH
    Microbiol Spectr; 2022 Jun; 10(3):e0064422. PubMed ID: 35435755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNase E Promotes Expression of Type III Secretion System Genes in Pseudomonas aeruginosa.
    Sharp JS; Rietsch A; Dove SL
    J Bacteriol; 2019 Nov; 201(22):. PubMed ID: 31481542
    [No Abstract]   [Full Text] [Related]  

  • 30. Killing from the inside: Intracellular role of T3SS in the fate of Pseudomonas aeruginosa within macrophages revealed by mgtC and oprF mutants.
    Garai P; Berry L; Moussouni M; Bleves S; Blanc-Potard AB
    PLoS Pathog; 2019 Jun; 15(6):e1007812. PubMed ID: 31220187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pore-forming activity of the Pseudomonas aeruginosa type III secretion system translocon alters the host epigenome.
    Dortet L; Lombardi C; Cretin F; Dessen A; Filloux A
    Nat Microbiol; 2018 Mar; 3(3):378-386. PubMed ID: 29403015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Structure-Function-Inhibition Analysis of the
    Moir DT; Bowlin NO; Berube BJ; Yabut J; Mills DM; Nguyen GT; Aron ZD; Williams JD; Mecsas J; Hauser AR; Bowlin TL
    J Bacteriol; 2020 Aug; 202(18):. PubMed ID: 32601072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acetylation of the CspA family protein CspC controls the type III secretion system through translational regulation of exsA in Pseudomonas aeruginosa.
    Li S; Weng Y; Li X; Yue Z; Chai Z; Zhang X; Gong X; Pan X; Jin Y; Bai F; Cheng Z; Wu W
    Nucleic Acids Res; 2021 Jul; 49(12):6756-6770. PubMed ID: 34139014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LcrQ blocks the role of LcrF in regulating the Ysc-Yop type III secretion genes in Yersinia pseudotuberculosis.
    Li L; Yan H; Feng L; Li Y; Lu P; Hu Y; Chen S
    PLoS One; 2014; 9(3):e92243. PubMed ID: 24658611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Iron availability and oxygen tension regulate the Yersinia Ysc type III secretion system to enable disseminated infection.
    Hooker-Romero D; Mettert E; Schwiesow L; Balderas D; Alvarez PA; Kicin A; Gonzalez AL; Plano GV; Kiley PJ; Auerbuch V
    PLoS Pathog; 2019 Dec; 15(12):e1008001. PubMed ID: 31869388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heterologous Complementation Studies With the YscX and YscY Protein Families Reveals a Specificity for
    Gurung JM; Amer AAA; Francis MK; Costa TRD; Chen S; Zavialov AV; Francis MS
    Front Cell Infect Microbiol; 2018; 8():80. PubMed ID: 29616194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthetic Cyclic Peptomers as Type III Secretion System Inhibitors.
    Lam H; Schwochert J; Lao Y; Lau T; Lloyd C; Luu J; Kooner O; Morgan J; Lokey S; Auerbuch V
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28652236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Putative RNA Ligase RtcB Affects the Switch between T6SS and T3SS in
    Dadashi M; Chen L; Nasimian A; Ghavami S; Duan K
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. tRNA modification enzyme MiaB connects environmental cues to activation of Pseudomonas aeruginosa type III secretion system.
    Lin Q; Huang J; Liu Z; Chen Q; Wang X; Yu G; Cheng P; Zhang LH; Xu Z
    PLoS Pathog; 2022 Dec; 18(12):e1011027. PubMed ID: 36469533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting the Type Three Secretion System in Pseudomonas aeruginosa.
    Anantharajah A; Mingeot-Leclercq MP; Van Bambeke F
    Trends Pharmacol Sci; 2016 Sep; 37(9):734-749. PubMed ID: 27344210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.